ALLE stock · BRNS stock

ALLE vs BRNS · P/E 21, rev $2.19B vs $38.2M cap

Allegion PLC (ALLE) versus Barinthus Biotherapeutics plc (BRNS) — a side-by-side from cached financials, not a winner call.

Allegion PLC (ALLE) is a security & protection services company listed on US.

Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.

Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.

Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.

ALLE currently screens at market cap $12.71B and trailing P/E 20.7. BRNS currently screens at market cap $38.2M.

Not investment advice. Open the ALLE and BRNS stock pages for the full models.

Not investment advice.

Popular Stock Comparisons